The synthetic absorbable surgical suture NEOSORB-PGLA RAPID (RPGLA) is indicated for the approximation of soft tissues, oral mucosa, plastic surgery, and generally where only short-term support is required. Its use is not indicated for the tissues of the central cardiovascular, central nervous, and ophthalmic systems.

After implantation, the synthetic absorbable surgical suture RAPID PGLA (RPGLA) initially causes a mild inflammatory reaction in the tissue, followed by the gradual formation of a fibrous tissue capsule.

• The suture RAPID PGLA (RPGLA) is degraded through hydrolysis processes, where the copolymer breaks down into glycolic and lactic acid.
• Residual strength of 50% after 5 days.
• The initial strength of the suture is lost within 10-14 days after implantation.
• The absorption of the suture is completed within 42 days.